| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/30/1997 | CN1155844A Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 07/30/1997 | CN1155842A Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 07/30/1997 | CN1155836A Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 07/30/1997 | CN1155835A Oestradiol transdermal therapeutic system comprising hydroscopic additives |
| 07/30/1997 | CN1155424A Pharmaceutics for Meniere's disease |
| 07/30/1997 | CN1155423A Pingyasan for hypertension |
| 07/30/1997 | CN1155422A Kangfusan for curing bed sore and its preparation |
| 07/30/1997 | CN1155418A Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 07/30/1997 | CN1155417A Oral formulations of S(+)-ibuprofen |
| 07/30/1997 | CN1155416A Health-care incenses and their production |
| 07/29/1997 | US5652339 Method of producing reconstituted lipoproteins |
| 07/29/1997 | US5652256 Naftifine hydrochloride gel containing methyl acetate penetration enhancing compound |
| 07/29/1997 | US5652254 Treatment of degenerative diseases, rheumatoid arthritis, psoriasis, cystic fibrosis |
| 07/29/1997 | US5652244 Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
| 07/29/1997 | US5652227 Inhibition of the degradation of connective tissue matrix protein components in mammals |
| 07/29/1997 | US5652220 Containing copolymer of lactic acid and glycolic acid and active agent in water in oil emulsion |
| 07/29/1997 | US5652216 Pharmaceutical preparation |
| 07/29/1997 | US5652212 Cyclosporin galenic forms |
| 07/29/1997 | US5652209 Administering transforming growth factor |
| 07/29/1997 | US5651991 Fatty emulsion of non-liposome particles containing drug in core, and having lipid surface layer |
| 07/29/1997 | US5651990 Prolonged release microparticle preparation and production of the same |
| 07/29/1997 | US5651989 Iron/carbon particles for drug delivery, using an external magnetic field to direct drug to target area inside body |
| 07/29/1997 | US5651988 Combination osmotic and bulk forming laxatives |
| 07/29/1997 | US5651987 Ulcer prevention and treatment composition |
| 07/29/1997 | US5651986 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 07/29/1997 | US5651985 Expandable pharmaceutical forms |
| 07/29/1997 | US5651984 Controlled release potassium tablet |
| 07/29/1997 | US5651983 Bisacodyl dosage form for colonic delivery |
| 07/29/1997 | US5651982 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 07/29/1997 | US5651981 Cationic phospholipids for transfection |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/29/1997 | US5651979 Apparatus and method for delivering a biologically active compound into a biological environment |
| 07/29/1997 | US5651977 Adherent disinfecting compositions and methods relating thereto |
| 07/29/1997 | US5651976 Controlled release of active agents using inorganic tubules |
| 07/29/1997 | US5651973 Therapeutically effective topical application of ST1435 |
| 07/29/1997 | US5651962 Dry pre-shaving composition |
| 07/29/1997 | US5651957 Administering lantibiotic |
| 07/29/1997 | US5651359 Device for inhaling powder |
| 07/29/1997 | CA1339190C Compositions and methods of manufacture of compressed powder medicaments |
| 07/29/1997 | CA1339108C Detergent compositions comprising encapsulated enzyme |
| 07/29/1997 | CA1339089C Microcrystalline matrix for controlled administration of beneficial agent |
| 07/29/1997 | CA1339088C Controlled administration of beneficial agent to blood |
| 07/29/1997 | CA1339082C Directly compressible sustained release excipient |
| 07/29/1997 | CA1339081C Delayed release formulations |
| 07/29/1997 | CA1339080C Methods and compositions for noninvasive dose-to-effect adminsitration of drugs with cardiovascular or renal vascular acitivities |
| 07/29/1997 | CA1339079C Controlled release device with an impermeable coating having an orifice for release of drug |
| 07/29/1997 | CA1339078C Controlled release pharmaceutical preparation and method for producing the same |
| 07/29/1997 | CA1339077C Liposome-encapsulated vinca alkaloids and their use in combatting tumors |
| 07/29/1997 | CA1339076C Opioid analgesic liposomal delivery - release system |
| 07/29/1997 | CA1339075C Methods and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
| 07/29/1997 | CA1339074C Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene |
| 07/29/1997 | CA1339072C Pharmaceutical formulation as well as a process for its preparation |
| 07/24/1997 | WO1997026308A1 Stabilized gas-enriched and gas-supersaturated liquids |
| 07/24/1997 | WO1997026021A1 Methods, compositions and articles for contraception |
| 07/24/1997 | WO1997026015A1 Sustained release drug formulations |
| 07/24/1997 | WO1997026003A1 Cyclosporin formulation |
| 07/24/1997 | WO1997025990A1 High-content famciclovir tablets |
| 07/24/1997 | WO1997025989A1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
| 07/24/1997 | WO1997025980A1 Topical delivery of drugs to the lower gastrointestinal tract |
| 07/24/1997 | WO1997025979A1 Gastrointestinal drug delivery system |
| 07/24/1997 | WO1997025978A1 Method of obtaining perfluorocarbon emulsions for medical purposes |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997025976A1 Anthelmintic paste |
| 07/24/1997 | WO1997025963A1 Hair conditioning compositions |
| 07/24/1997 | WO1997025959A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| 07/24/1997 | WO1997025936A1 Buffered resorbable internal fixation devices for repair of bone fractures |
| 07/24/1997 | DE19620117C1 Preparation of medicinal composition containing calcium sulphate |
| 07/24/1997 | DE19602208A1 In-situ gebildete Arzneiform zur Abgabe von Enzymen an Wunden In-situ formed dosage form for delivering enzymes to wounds |
| 07/24/1997 | DE19602206A1 Zubereitungen nichtsteroidaler Analgetika Preparations of non-steroidal analgesics |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2248638A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | CA2244421A1 Topical delivery of drugs to the lower gastrointestinal tract |
| 07/23/1997 | EP0785221A2 Adhesives resistant to skin-penetration enhancers |
| 07/23/1997 | EP0784984A2 Transfection competent molecules |
| 07/23/1997 | EP0784975A1 Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries |
| 07/23/1997 | EP0784974A1 Solid dispersion or solid dispersion preparation of xanthine derivatives |
| 07/23/1997 | EP0784972A2 Cosmetic and/or pharmaceutical emulsions |
| 07/23/1997 | EP0784506A1 Method of coating particles |
| 07/23/1997 | EP0784490A1 Differentially biodegradable biomedical implants |
| 07/23/1997 | EP0784485A1 Vaccine compositions |
| 07/23/1997 | EP0784481A1 Wound healing formulations containing human plasma fibronectin |
| 07/23/1997 | EP0784474A2 Parenteral pharmaceutical compositions containing gf120918a |
| 07/23/1997 | EP0784470A1 Liposome-formulations for treatment of viral diseases |
| 07/23/1997 | EP0784469A1 Compositions for the delivery of antigens |
| 07/23/1997 | EP0784468A1 Phospholipid- and cholesterol-free aqueous composition for topical application to the skin |
| 07/23/1997 | EP0784467A1 Unitary vaginal dosage form useful as a local contraceptive and/or for combatting sexually transmitted diseases and/or hiv |
| 07/23/1997 | EP0784466A1 Use and composition of an anti-sexually transmitted diseases formulation |
| 07/23/1997 | EP0784429A1 Method and formulation of stimulating nitric oxide synthesis |
| 07/23/1997 | EP0641236B1 A method for coated particles in a spray-drying plant |
| 07/23/1997 | EP0641192B1 Transmucosal drug delivery device |
| 07/23/1997 | EP0637957B1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases |
| 07/23/1997 | EP0630229B1 Pressurized gas packagings using polyoxyethylene glyceryl-obates |
| 07/23/1997 | EP0599914B1 Pharmacologically enhanced formulations |
| 07/23/1997 | EP0528998B1 Periodontal tissue regeneration barrier |
| 07/23/1997 | EP0477386B1 Pharmaceutical aerosol formulation of solid polypeptide microparticles and method for the preparation thereof |
| 07/23/1997 | CN2258066Y Medicinal pad for curing diarrhea |
| 07/23/1997 | CN1155287A Cross-linked polymers for removing bile salts from patient |
| 07/23/1997 | CN1155247A Aqueous risperidone formulations |
| 07/23/1997 | CN1155245A Use of muramyl peptide compounds |
| 07/23/1997 | CN1155242A Liquid pharmaceutical composition for controlled release of moguisteine |